$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000162828022026757 Filed on October 20, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$1.847M	$1.968M
YoY Change	1.5%	-4.67%
Cost Of Revenue	$617.3K	$693.6K
YoY Change	6.89%	11.9%
Gross Profit	$1.230M	$1.274M
YoY Change	-1.01%	-11.78%
Gross Profit Margin	66.59%	64.76%
Selling, General & Admin	$1.548M	$1.912M
YoY Change	23.85%	35.83%
% of Gross Profit	125.86%	150.06%
Research & Development	$538.4K	$1.075M
YoY Change	-46.0%	48.36%
% of Gross Profit	43.77%	84.35%
Depreciation & Amortization	$10.22K	$12.89K
YoY Change	-137.56%	-46.47%
% of Gross Profit	0.83%	1.01%
Operating Expenses	$2.087M	$2.987M
YoY Change	-7.15%	40.09%
Operating Profit	-$856.5K	-$1.713M
YoY Change	-14.73%	148.99%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$164.6K	$106.7K
YoY Change	11021.62%	12029.55%
Pretax Income	-$691.9K	-$1.606M
YoY Change	-31.02%	133.78%
Income Tax
% Of Pretax Income
Net Earnings	-$691.9K	-$1.606M
YoY Change	-31.02%	133.78%
Net Earnings / Revenue	-37.45%	-81.62%
Basic Earnings Per Share		-$0.23
Diluted Earnings Per Share	-$0.09	-$0.23
COMMON SHARES
Basic Shares Outstanding	7.757M shares	7.130M shares
Diluted Shares Outstanding		7.025M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.20M	$20.83M
YoY Change	-6.08%	-10.28%
Cash & Equivalents	$21.20M	$1.772M
Short-Term Investments	$16.95M	$19.05M
Other Short-Term Assets	$2.907M	$845.7K
YoY Change	385.86%	19.08%
Inventory	$1.615M	$1.057M
Prepaid Expenses
Receivables	$646.8K	$702.5K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$24.11M	$23.43M
YoY Change	-0.33%	-8.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$165.6K	$175.8K
YoY Change	-16.65%	-14.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$562.6K	$26.40K
YoY Change	2031.17%	-9.87%
Total Long-Term Assets	$562.6K	$600.4K
YoY Change	-19.66%	-18.12%
TOTAL ASSETS
Total Short-Term Assets	$24.11M	$23.43M
Total Long-Term Assets	$562.6K	$600.4K
Total Assets	$24.67M	$24.03M
YoY Change	-0.88%	-8.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$368.1K	$539.4K
YoY Change	29.59%	70.17%
Accrued Expenses	$589.9K	$1.135M
YoY Change	-27.54%	10.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.106M	$1.832M
YoY Change	-18.99%	5.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$207.5K	$233.7K
YoY Change	-32.34%	-29.01%
Total Long-Term Liabilities	$207.5K	$233.7K
YoY Change	-32.34%	-29.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.106M	$1.832M
Total Long-Term Liabilities	$207.5K	$233.7K
Total Liabilities	$1.314M	$2.066M
YoY Change	-21.43%	0.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$203.6M	-$202.9M
YoY Change	2.22%	2.39%
Common Stock	$778.00	$714.00
YoY Change	16.29%	7.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.36M	$21.97M
YoY Change
Total Liabilities & Shareholders Equity	$24.67M	$24.03M
YoY Change	-0.88%	-8.6%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$691.9K	-$1.606M
YoY Change	-31.02%	133.78%
Depreciation, Depletion And Amortization	$10.22K	$12.89K
YoY Change	-137.56%	-46.47%
Cash From Operating Activities	-$1.483M	-$2.228M
YoY Change	189.39%	124.46%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$9.750K
YoY Change	-100.0%	-76.66%
Acquisitions
YoY Change
Other Investing Activities	$2.051M	-$1.993M
YoY Change
Cash From Investing Activities	$2.051M	-$2.003M
YoY Change	-30851.27%	4694.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.913M	0.000
YoY Change	-1664.18%	-100.0%
NET CHANGE
Cash From Operating Activities	-1.483M	-2.228M
Cash From Investing Activities	2.051M	-2.003M
Cash From Financing Activities	1.913M	0.000
Net Change In Cash	2.481M	-4.230M
YoY Change	-486.83%	-128.49%
FREE CASH FLOW
Cash From Operating Activities	-$1.483M	-$2.228M
Capital Expenditures	$0.00	-$9.750K
Free Cash Flow	-$1.483M	-$2.218M
YoY Change	193.21%	133.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Local Phone Number LocalPhoneNumber	890-9989
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33351
	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	City Area Code CityAreaCode	781
	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
	dei	Trading Symbol TradingSymbol	NURO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7757226	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1772005	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22572104	usd
CY2022Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	19054654	usd
CY2021Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	0	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	702459	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	310818	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1057239	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	706553	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	845649	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	598384	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	23432006	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	24187859	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	175840	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	198703	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	398144	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	475230	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26400	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26400	usd
CY2022Q3	us-gaap	Assets Assets	24032390	usd
CY2021Q4	us-gaap	Assets Assets	24888192	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	539379	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	284036	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1134659	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	814155	usd
CY2022Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	10000	usd
CY2021Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	39000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	228506	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1832429	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1365697	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	233693	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	306709	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2066122	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1672406	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7137519	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7137519	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6694296	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6694296	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	714	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	669	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	224853549	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	222378373	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-202887996	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199163257	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	21966268	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23215786	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24032390	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24888192	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1968003	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2064359	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6408695	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6433330	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	693571	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	619833	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1888566	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1754343	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1274432	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	1444526	usd
	us-gaap	Gross Profit GrossProfit	4520129	usd
	us-gaap	Gross Profit GrossProfit	4678987	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1074954	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	724556	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2701330	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1599358	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	810209	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	442230	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2235646	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1105548	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1102260	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	965711	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3468452	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3254210	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2987423	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2132497	usd
	us-gaap	Operating Expenses OperatingExpenses	8405428	usd
	us-gaap	Operating Expenses OperatingExpenses	5959116	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1712991	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-687971	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3885299	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1280129	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	106737	usd
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	882	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	160560	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1673	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1606254	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3724739	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1278456	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	68863	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4197	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5261052	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	319863	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3766848	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18950	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-531584	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	8835129	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	196361	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15805110	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	78500	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	24228011	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23215786	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37632	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1943052	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24237908	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	109340	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7829	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	215417	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1159923	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23410571	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	161951	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1606254	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	21966268	usd
	us-gaap	Profit Loss ProfitLoss	-3724739	usd
	us-gaap	Profit Loss ProfitLoss	-1278456	usd
	us-gaap	Depreciation Depreciation	39170	usd
	us-gaap	Depreciation Depreciation	103594	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	308923	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	585087	usd
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	26019	usd
	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	usd
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	0	usd
	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	126748	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6875	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	nuro	Interest Income Accretion Held To Maturity Securities InterestIncomeAccretionHeldToMaturitySecurities	133278	usd
	nuro	Interest Income Accretion Held To Maturity Securities InterestIncomeAccretionHeldToMaturitySecurities	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	391641	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	305469	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	350686	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-54331	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	383310	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	612661	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	255343	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	174653	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	569902	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	89931	usd
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-29000	usd
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-499000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3806422	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1561242	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	18921376	usd
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23182	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	125039	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18944558	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125039	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1950881	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	19673605	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1950881	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19673605	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20800099	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17987324	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22572104	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5226213	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1772005	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23213537	usd
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	189398	usd
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	usd
CY2022Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	20800000	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	usd
CY2022Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	18937643	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1606254	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-687089	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3724739	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1278456	usd
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7025254	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7025254	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5818449	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5818449	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6976548	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6976548	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4597580	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4597580	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	839313	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	514809	shares
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	461349	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	422093	usd
CY2022Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	595890	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	284460	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	1057239	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	706553	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	277000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	109000	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	522044	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	440474	usd
CY2022Q3	nuro	Accrued Consulting Current AccruedConsultingCurrent	125000	usd
CY2021Q4	nuro	Accrued Consulting Current AccruedConsultingCurrent	5000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	28400	usd
CY2022Q3	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	0	usd
CY2021Q4	nuro	Accrued Leaseholds Current AccruedLeaseholdsCurrent	60000	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	143136	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	108788	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	49479	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	62493	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1134659	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	814155	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41446	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	165785	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	165785	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	117431	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	490447	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2022Q3	nuro	Operating Lease Discount OperatingLeaseDiscount	108363	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	233693	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	490447	usd
CY2022Q1	nuro	Rent Expense Reduction RentExpenseReduction	60000	usd
	us-gaap	Sublease Income SubleaseIncome	22795	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	46102	usd
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	18932	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	116959	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	243289	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2022Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	76000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	326000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	161764	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	550000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	57972	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	202008	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1224278	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	10702	shares
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18950	usd

Files In Submission

Name	View Source	Status
0001628280-22-026757-index-headers.html	Edgar Link	pending
0001628280-22-026757-index.html	Edgar Link	pending
0001628280-22-026757.txt	Edgar Link	pending
0001628280-22-026757-xbrl.zip	Edgar Link	pending
a10q9302022ex311.htm	Edgar Link	pending
a10q9302022ex312.htm	Edgar Link	pending
a10q9302022ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20220930.htm	Edgar Link	pending
nuro-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
nuro-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nuro-20220930_def.xml	Edgar Link	unprocessable
nuro-20220930_lab.xml	Edgar Link	unprocessable
nuro-20220930_pre.xml	Edgar Link	unprocessable
nuro-20220930_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2022 Q4 Form 10-Q Financial Statement

#000162828022026757 Filed on October 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2022 Q4 Form 10-Q Financial Statement

#000162828022026757 Filed on October 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro